Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease
about
Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environmentSynergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injuryTherapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord InjuryNeural stem cell niches in health and diseasesHow do immune cells support and shape the brain in health, disease, and aging?Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in miceFriend or foe: the dichotomous impact of T cells on neuro-de/re-generation during agingExcess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitisPro-cognitive properties of T cells.Vaccine for the mind: Immunity against self at the choroid plexus for erasing biochemical consequences of stressful episodesFunctional efficacy of glatiramer acetate treatment for laser-induced retinal damage in rats.Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigensAbnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS.Enhanced functional recovery in MRL/MpJ mice after spinal cord dorsal hemisection.Development of protective autoimmunity by immunization with a neural-derived peptide is ineffective in severe spinal cord injury.CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain.Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift.Role reversal: infiltrating T cells protect the brain.Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injuryCell biology and clinical promise of G-CSF: immunomodulation and neuroprotection.Cellular transplantation strategies for spinal cord injury and translational neurobiologyAutoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants.The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion.Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy.Inflammation and Spinal Cord Injury: Infiltrating Leukocytes as Determinants of Injury and Repair Processes.Application of glatiramer acetate to neurodegenerative diseases beyond multiple sclerosis: the need for disease-specific approaches.Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis.Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers.Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury.Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.The role of glutamate and the immune system in organophosphate-induced CNS damage.The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus.Effects of Physical Exercise on Neuroinflammation, Neuroplasticity, Neurodegeneration, and Behavior: What We Can Learn From Animal Models in Clinical Settings.Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators.FTY720 reduces inflammation and promotes functional recovery after spinal cord injury.Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteinsHormonal therapy in traumatic spinal cord injury.Cellular neuroinflammation in a lateral forceps compression model of spinal cord injury.Immune-related mechanisms participating in resistance and susceptibility to glutamate toxicity.
P2860
Q24633514-C1C2BADE-1FC4-451A-9063-EA74049B79C5Q24678231-E26322E3-08EE-4589-A8B5-02E3F0D2FF92Q24681228-3A4DE8AD-9D5D-419D-8E85-FA49FA103069Q26740237-955B88C4-445C-4749-BED9-7C089142A6C5Q26995185-3C1603FC-056D-4313-AFCE-049BC3D8783FQ26995364-48DFD923-8690-412A-BE0B-18FA70F8FCBDQ27307172-95C42454-6B5F-42F0-AB61-F0816EC92C67Q28077869-DCAE9D98-3160-48E0-8359-DC3FE1110758Q28743158-D5740DCE-11F8-4AAF-B8B4-FA2F8D8DC9DFQ30412966-84D5A3FD-B5E4-4438-BFDE-3B2A811ABB88Q30448649-32D26FDA-F7A5-4A7A-889D-65197ADFEB56Q33325562-C59AEA69-5022-4A88-9FAD-C26B2934BA65Q33953007-53C2BDE0-58B5-4852-B327-C40A8757C282Q33988381-DD73F3AF-BC58-4CED-8141-90C929AE60F3Q34163301-9DC59C24-1871-42F9-B110-870A49C9C68CQ34163814-0167055E-3358-49C4-ADD1-4786A2C4CC4CQ34235603-71084DFE-A0F3-4B4E-9231-AE34DD383035Q34956279-64720787-BC51-4489-B133-96608A00D4B9Q35056732-18EAB06E-83E1-413C-A189-3E23FF04218CQ35121911-3B9D461B-1880-40DD-80FA-D1B0700C18D7Q35459801-4711C251-4631-4FF4-9C9D-B944F91B1FBFQ36045383-A5623003-3631-4140-BD3F-206C90D66AC0Q36255289-F2AA7608-A89A-4176-82A7-FC33B26CEED6Q36455702-28C91D14-D7AF-4B8A-9223-B686255F1128Q37015369-562BED20-C61F-408F-8E64-0F4FD105F883Q37024745-27232E61-F464-43B3-9EBF-5A7D4F3F37F2Q37263175-DE4B9141-4B66-44FE-A92A-0C104E5EA24AQ37295387-53F92691-52D5-4642-9314-1D64AAD0B0F8Q37461052-4420094C-5CDF-4117-ACD6-722D4A2D48BCQ37741027-2EEA233E-151A-4877-8FB5-3F02C242C8AFQ37781306-A301CEE6-51C4-4127-AC39-3D5878893F57Q38093477-F78D0648-B10D-47B3-83A3-D9E1FCD42B27Q38172891-F777CC7C-5661-4E34-A6E1-D256EEDD1C7FQ38295210-C01F0B38-7DEB-43F1-BC5F-557C650BA897Q38330556-B97CE142-5F7C-420A-ACDC-962CCCEF1941Q39918468-A597146B-35FA-4AD0-9280-F2732744CFC8Q41825402-ED3CDFF1-768A-45C3-A68F-E1390655ACDCQ41906811-96CEE32E-F2C0-4EC1-BBD6-189F91B36CB0Q44014570-A76C11A7-B4D2-4078-B9E3-47B44D71A597Q44148321-21431E8F-C31D-4D4E-B526-677D05FA7AFE
P2860
Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Posttraumatic therapeutic vacc ...... le avoiding autoimmune disease
@ast
Posttraumatic therapeutic vacc ...... le avoiding autoimmune disease
@en
Posttraumatic therapeutic vacc ...... le avoiding autoimmune disease
@nl
type
label
Posttraumatic therapeutic vacc ...... le avoiding autoimmune disease
@ast
Posttraumatic therapeutic vacc ...... le avoiding autoimmune disease
@en
Posttraumatic therapeutic vacc ...... le avoiding autoimmune disease
@nl
prefLabel
Posttraumatic therapeutic vacc ...... le avoiding autoimmune disease
@ast
Posttraumatic therapeutic vacc ...... le avoiding autoimmune disease
@en
Posttraumatic therapeutic vacc ...... le avoiding autoimmune disease
@nl
P2093
P2860
P3181
P356
P1476
Posttraumatic therapeutic vacc ...... le avoiding autoimmune disease
@en
P2093
L Steinman
M Schwartz
P2860
P3181
P356
10.1172/JCI12837
P407
P577
2001-08-01T00:00:00Z